This introduction to the special issue on crowdfunding begins by providing some information about the history and nature of the phenomenon. It then summarizes some of the key advantages and disadvantages of crowdfunding for entrepreneurs and for investors, introducing the various articles in the issue that explore these topics in greater depth. It concludes with some speculations regarding the possible future of the industry and its effects on entrepreneurship, innovation, and inequality.
Dean Venky of the newly launched School of Engineering and Applied Sciences is faced with a range of opportunities and challenges as he presides over the launching of a new school of engineering at Harvard University. His opportunities include an ample endowment, a small but elite faculty, and the potential to collaborate with the other schools within Harvard. His challenges include attracting the best faculty and students, creating linkages across the university, and determining a strategy that will make Harvard engineering as well known as its other schools. Students must analyze the engineering school's strengths and weaknesses relative to other top schools, the political challenges of organizational change, and the most appropriate strategy for the Dean to follow.
This is an MIT Sloan Management Review article. The largely erroneous perception that breakthroughs are impossible to predict arises from the tendency to focus on just the breakthroughs while ignoring the iterative process of invention and its distribution of outcomes. When all inventions are considered, they demonstrate a highly skewed distribution in which almost all inventions are useless, a few are of moderate value, and only a very, very few are breakthroughs. Those breakthroughs constitute the "long tail" of innovation. If managers wish to understand how those breakthroughs arise, they cannot ignore the process that generates the entire distribution. In particular, they need to keep in mind the following three measures of inventive success: shots on goal (the total number of inventions a company generates), average score (the mean value of those inventions), and maximum scores (the breakthrough inventions). Various factors can affect a company's inventive output, including the presence of inventors who work alone, the type of collaboration among those inventors who work in teams, the amount of team diversity, and the degree to which inventors apply science in the innovation process. Greater team diversity, for instance, will help generate more shots on goal although, on average, those shots will be less successful. But diversity also will increase the variance of the outcome, so that failures as well as breakthroughs are more likely. Thus companies first need to identify how they want to improve their innovation process and then take the appropriate measures to address any deficiencies. Only then can they improve their capacity to innovate in ways that make the best sense for the organization as a whole.
The challenges and best strategies for the commercialization of university technologies are illustrated in this case which documents an MRI breakthrough that arose from the Charles Marcus laboratory at Harvard. Students discuss the interdependencies of intellectual property protection, strategy choices for science based breakthroughs, and business models for university technology.
Robert K. Merton wrote a series of papers on the sociology of science in the 1940s and 1950s and is commonly recognized as the founder of the field. Merton laid out four norms that constitute the "ethos" of science: community-wide fundamentals that he proposed were necessary to sustain science as a viable institution.
Greater job mobility among engineers and scientists has caused the extended social networks of inventors to become increasingly connected. As a result, invention increasingly occurs within small worlds (or social networks) that straddle firm boundaries. Small worlds provide both strategic opportunity and potential threat; while they can increase creativity within a firm, they also aid in the diffusion of creative knowledge to other firms through personnel and knowledge transfer. Firms that operate within small worlds, such as Silicon Valley, long ago learned to manage invention in an environment of rampant knowledge spillovers across firm boundaries. Now, however, all firms need to learn how to manage innovation in a small world environment. offers advice about how to do so.
Brandon Fogg must solve two seemingly unrelated problems in his management of creative R&D professionals. First, despite having hired brilliant research professionals, his firm is having problems commercializing their ideas. Second, his most brilliant engineer has invented a breakthrough, but refuses to assign the intellectual property to the firm, despite having agreed to do so in his employment contract. Fogg must choose from a variety of options, including prosecution of a noncompete agreement.
Stan Williams, leading nanotech researcher at Hewlett Packard Laboratories, must decide whether to renew the firm's sponsorship of California NanoSystems Institute, spend the funds on internal R&D, or fund foreign universities. Illustrates the challenge of managing firm-university collaborations and develops implications for national competitiveness.
InfoVision illustrates university technology transfer through the choices of a graduating doctoral student. Also explores the challenges of working across the scientific, business, and legal disciplines in the Georgia Tech transfer program.
Students in a technology transfer class identify a promising application for a dormant university technology. In the process, they alienate the inventor, who threatens legal action. What exactly are the problems, and how should the professor teaching the class proceed?
There's a way to build cross-functional innovation teams that can balance your appetite for risk with your hunger for a breakthrough. Do it wrong, and you may find yourself with a highly creative team producing a string of bad ideas.
Vertex Pharmaceuticals, Inc., a drug discovery company that recently decided to pursue a vertically integrated business model, chose to build up its clinical development and commercial capabilities and infrastructure. For the first time in its history, Vertex will select two drug candidates from its internal research portfolio of four projects to develop on its own, without the help of strategic partners. CEO Joshua Boger and President Vicki Sato are grappling with which two projects to select. Focuses on how to select projects and how to manage the process of portfolio selection.
Social and professional networks are crucial to innovation. New research reveals that it takes just a few key players to catalyze the agglomeration of many small networks into larger ones and boost innovation across a whole region.
Illustrates the technological and organizational challenges of breakthrough innovation. Students discuss the benefits, disadvantages, and management of various approaches to technological breakthroughs.
Illustrates technology strategy, knowledge management, and the challenges of managing temporary professionals in the increasingly modular semiconductor industry.
Much has been made about how efficient it is to develop new products from independent, modular components. But 350 billion calculations on U.S. Patent Office data reveal that the true breakthrough products are more likely to come from designs that employ the far messier and more unpredictable interdependent parts.